# Polychlorinated Biphenyls, Oxidative Stress, and Brain Health: Mechanistic Links to Neurodegenerative and Neurodevelopmental Diseases

**Authors:** Aurelio Minuti, Alessia Floramo, Veronica Argento, Ivan Anchesi, Claudia Muscarà, Marco Calabrò, Serena Silvestro

PMC · DOI: 10.3390/antiox15020242 · Antioxidants · 2026-02-12

## TL;DR

This paper reviews how polychlorinated biphenyls (PCBs) harm brain health by causing oxidative stress and other cellular disruptions, leading to neurodevelopmental and neurodegenerative diseases.

## Contribution

The paper provides a comprehensive synthesis of PCB-induced neurotoxicity mechanisms, emphasizing oxidative stress as a central factor across the lifespan.

## Key findings

- PCBs disrupt neuronal function through oxidative stress, calcium dysregulation, and epigenetic changes.
- Developmental PCB exposure is linked to cognitive and motor impairments and neurodevelopmental disorders.
- Chronic PCB exposure in adulthood is associated with neurodegenerative diseases via mitochondrial dysfunction and neuroinflammation.

## Abstract

Polychlorinated biphenyls (PCBs) are persistent organic pollutants that remain widely detectable in the environment and human tissues decades after their ban, raising concerns for brain health. Both dioxin-like (DL) and non-dioxin-like (NDL) congeners interfere with neuronal function through partially distinct pathways, including aryl hydrocarbon receptor activation, disruption of calcium and dopaminergic signaling, oxidative stress, and epigenetic remodeling. Experimental and epidemiological studies indicate that developmental PCB exposure is associated with impaired cognition, attention, motor function, and increased risk of neurodevelopmental disorders. Furthermore, chronic exposure in adulthood has been linked to neurodegenerative diseases. At the cellular level, NDL-PCBs sensitize ryanodine receptors, alter dendritic and axonal growth, promote mitochondrial dysfunction, generate reactive oxygen and nitrogen species, and compromise blood–brain barrier integrity, thereby fostering neuroinflammation, synaptic dysfunction, and neuronal loss. This review synthesizes current evidence on the molecular and cellular mechanismtable s underlying PCB-induced neurotoxicity across the lifespan, highlighting oxidative stress as a central factor, integrating calcium dysregulation, neurotransmitter imbalance, and apoptotic and epigenetic pathways. Finally, potential neuroprotective roles of antioxidant strategies are discussed, emphasizing their relevance for mitigating PCB-related neurodevelopmental and neurodegenerative risk.

## Full-text entities

- **Genes:** AHRR (aryl hydrocarbon receptor repressor) [NCBI Gene 57491] {aka AHH, AHHR, bHLHe77}, SLC6A3 (solute carrier family 6 member 3) [NCBI Gene 6531] {aka DAT, DAT1, PKDYS, PKDYS1}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, DNAJC6 (DnaJ heat shock protein family (Hsp40) member C6) [NCBI Gene 9829] {aka DJC6, PARK19}, TFRC (transferrin receptor) [NCBI Gene 7037] {aka CD71, IMD46, T9, TFR, TFR1, TR}, SLC18A2 (solute carrier family 18 member A2) [NCBI Gene 6571] {aka PKDYS2, SVAT, SVMT, VAT2, VMAT2}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, HDAC3 (histone deacetylase 3) [NCBI Gene 8841] {aka HD3, KDAC3, RPD3, RPD3-2}, Ryr2 (ryanodine receptor 2) [NCBI Gene 689560] {aka RYR-2, RyR}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, TTR (transthyretin) [NCBI Gene 7276] {aka AMYLD1, ATTR, CTS, CTS1, HEL111, HsT2651}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, SLC1A2 (solute carrier family 1 member 2) [NCBI Gene 6506] {aka DEE41, EAAT2, EIEE41, GLT-1, GLT1, HBGT}, GSTA2 (glutathione S-transferase alpha 2) [NCBI Gene 2939] {aka GST2, GSTA2-2, GTA2, GTH2}, TARDBP (TAR DNA binding protein) [NCBI Gene 23435] {aka ALS10, TDP-43}, Slc6a3 (solute carrier family 6 (neurotransmitter transporter, dopamine), member 3) [NCBI Gene 13162] {aka DAT, Dat1}, POMC (proopiomelanocortin) [NCBI Gene 5443] {aka ACTH, CLIP, LPH, MSH, NPP, OBAIRH}, Ryr1 (ryanodine receptor 1, skeletal muscle) [NCBI Gene 20190] {aka RYR-1, Ryr, skrr}, ARNT (aryl hydrocarbon receptor nuclear translocator) [NCBI Gene 405] {aka ARNT1, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA}, HSP90AA1 (heat shock protein 90 alpha family class A member 1) [NCBI Gene 3320] {aka EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, Ahr (aryl-hydrocarbon receptor) [NCBI Gene 11622] {aka Ah, Ahh, Ahre, In, bHLHe76}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, Tardbp (TAR DNA binding protein) [NCBI Gene 230908] {aka 1190002A23Rik, TDP-43, Tdp43}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Slc18a2 (solute carrier family 18 (vesicular monoamine), member 2) [NCBI Gene 214084] {aka 1110037L13Rik, 9330105E13, Vmat2}, CYP4F3 (cytochrome P450 family 4 subfamily F member 3) [NCBI Gene 4051] {aka CPF3, CYP4F, CYPIVF3, LTB4H}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, SYN1 (synapsin I) [NCBI Gene 6853] {aka EPILX, EPILX1, MRX50, SYN1a, SYN1b, SYNI}, REST (RE1 silencing transcription factor) [NCBI Gene 5978] {aka DFNA27, GINGF5, HGF5, NRSF, WT6, XBR}, TH (tyrosine hydroxylase) [NCBI Gene 7054] {aka DYT14, DYT5b, TYH}, PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, AHR (aryl hydrocarbon receptor) [NCBI Gene 196] {aka FVH3, RP85, bHLHe76}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, PRDX1 (peroxiredoxin 1) [NCBI Gene 5052] {aka MSP23, NKEF-A, NKEFA, PAG, PAGA, PAGB}, MECP2 (methyl-CpG binding protein 2) [NCBI Gene 4204] {aka AUTSX3, MRX16, MRX79, MRXS13, MRXSL, PPMX}, CRH (corticotropin releasing hormone) [NCBI Gene 1392] {aka CRF, CRH1}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, Cyp1a2 (cytochrome P450, family 1, subfamily a, polypeptide 2) [NCBI Gene 13077] {aka CP12, CYPIA2, P450-3}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, WNT2 (Wnt family member 2) [NCBI Gene 7472] {aka INT1L1, IRP}, MIR132 (microRNA 132) [NCBI Gene 406921] {aka MIRN132, miRNA132, mir-132}, CLDN5 (claudin 5) [NCBI Gene 7122] {aka AWAL, BEC1, CPETRL1, TMDVCF, TMVCF}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}
- **Diseases:** ALS (MESH:D000690), hallucinations (MESH:D006212), axis (MESH:C566610), brain damage (MESH:D001925), death (MESH:D003643), defects in neuronal connectivity (MESH:D003240), delusions (MESH:D063726), carcinogenic (MESH:D011230), intellectual disability (MESH:D008607), Rett Syndrome (MESH:D015518), psychosis (MESH:D011618), ADHD (MESH:D001289), endocrine disruption (MESH:D004700), immune system dysfunction (MESH:D007154), motor conduction abnormalities (MESH:D054537), SLD (MESH:D000067559), cytotoxicity (MESH:D064420), Depressed (MESH:D003866), POPs (MESH:D000092124), hyperactive-impulsive symptoms (MESH:D007174), epileptiform activity (MESH:D014277), dopaminergic neuron degeneration (MESH:D009410), estrogen deficiency (MESH:D056828), executive dysfunction (MESH:D006331), Parkinson (MESH:D010302), low (MESH:D009800), dementia (MESH:D003704), Bipolar Disorders (MESH:D001714), Lewy pathology (MESH:D005598), Neurodevelopmental Disorders (MESH:D002658), MS (MESH:D009103), synaptic dysfunction (MESH:C536122), impaired memory (MESH:D008569), communication disorder (MESH:D003147), movement disorders (MESH:D009069), cognitive and behavioral dysfunction (MESH:D003072), dopaminergic (MESH:D009422), substantia nigra depigmentation (MESH:C000656904), condition (MESH:D020763), inflammation (MESH:D007249), Neurodegenerative diseases (MESH:D019636), injury to (MESH:D014947), mitochondrial dysfunction (MESH:D028361), PD (MESH:D010300), impaired visual memory (MESH:D014786), sleep disturbances (MESH:D012893), ASD (MESH:D000067877), cancers (MESH:D009369), muscle weakness (MESH:D018908), Developmental Neurotoxicity (MESH:D020258), AD (MESH:D000544), Mental Disorders (MESH:D001523), Schizophrenia (MESH:D012559), neuroinflammation (MESH:D000090862), Anxiety (MESH:D001007), Lewy body pathology (MESH:D020961), -disrupting (MESH:D019958), Autism (MESH:D001321), neurological diseases (MESH:D020271), autoimmune conditions (MESH:D001327)
- **Chemicals:** Dioxin (MESH:D004147), 2,3,7,8-Tetrachlorodibenzo-p-dioxin (MESH:D000072317), PBDEs (MESH:D055768), NDL-PCBs (-), T4 (MESH:D013974), PCBs (MESH:D011078), phthalates (MESH:C032279), PCB95 (MESH:C032904), mercury (MESH:D008628), isosafrole (MESH:C015959), RNS (MESH:D026361), chlorpyrifos (MESH:D004390), catecholamine (MESH:D002395), PVC (MESH:D011143), carbamates (MESH:D002219), chlorine (MESH:D002713), valproic acid (MESH:D014635), glutathione (MESH:D005978), ATP (MESH:D000255), THs (MESH:D013910), alpha-tocopherol (MESH:D024502), cysteine (MESH:D003545), lipid (MESH:D008055), T3 (MESH:D014284), DA (MESH:D004298), Calcium (MESH:D002118), ROS (MESH:D017382), EDC (MESH:C024565), folate (MESH:D005492), Dimethyl sulfoxide (MESH:D004121), serotonin (MESH:D012701), vitamin D (MESH:D014807), glucuronide (MESH:D020719), vinclozolin (MESH:C025643), sulfate (MESH:D013431), Aroclor 1221 (MESH:C032739), 4-OH-2,3,3',4',5-pentachlorobiphenyl (MESH:C501474), quercetin (MESH:D011794), nitrogen (MESH:D009584), omega-3 fatty acids (MESH:D015525), 17beta-estradiol (MESH:D004958), HVA (MESH:D006719), pyrethroids (MESH:D011722), organochlorine compounds (MESH:D006843), corticosterone (MESH:D003345), 3,4-Dihydroxyphenylacetic acid (MESH:D015102), lead (II) chloride (MESH:C029891), PCB138 (MESH:C029790), water (MESH:D014867), bisphenol A (MESH:C006780), iron (MESH:D007501), 3-nitrotyrosine (MESH:C002744), Aroclor 1254 (MESH:D020111), Aroclor (MESH:D001140), ICI182,780 (MESH:D000077267), 4-hydroxynonenal (MESH:C027576), biphenyl (MESH:C010574), glutamate (MESH:D018698), norepinephrine (MESH:D009638), GABA (MESH:D005680)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mustela putorius furo (black ferret, subspecies) [taxon 9669], Clostridium (genus) [taxon 1485], Cetacea (cetaceans, infraorder) [taxon 9721], Mus musculus (house mouse, species) [taxon 10090], Ovis aries (domestic sheep, species) [taxon 9940]
- **Mutations:** R163C
- **Cell lines:** SN56 — Mus musculus (Mouse), Hybrid cell line (CVCL_4456), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937811/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937811/full.md

## References

275 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937811/full.md

---
Source: https://tomesphere.com/paper/PMC12937811